Discovery of Genetic Basis of Monogenic Heart, Lung, Blood, and Sleep Disorders RFA

Purpose: To stimulate discoveries of the genetic basis of Mendelian or monogenic disorders that significantly affect heart, lung, blood, and sleep (HLBS) systems, the National Heart, Lung, and Blood Institute (NHLBI) will provide free genome-wide sequencing service to investigators conducting genetic discovery research of monogenic heart, lung, blood, and sleep disorders.

The studies facilitatedby this Funding Opportunity Announcement (FOA) must have existing genomic DNA samples collected from patients with suspected Mendelian or monogenic disorders and propose to use the whole exome sequencing (WES) or whole genome sequencing (WGS) capacity of the Centers of Mendelian Genomics funded under RFA-HG-15-002. No funds will be provided to collect samples or conduct analyses. Applications must focus on heart, lung, blood, and sleep (HLBS) disorders likely influenced by genetic variant(s) in a single gene.

Application Due Date: June 15, 2016, June 15, 2017 and June 15, 2018 by 5 p.m.

For the full details, click here: